Historical approaches to the treatment of Adductor-Type Spasmodic Dysphonia (ADSD): Review and tutorial

No abstract is available for this paper.

• Publication year

  2003

• Venue

  NeuroRehabilitation (Reading, MA)

• Publication date

  2003-12-16

• Fields of study

  Medicine, Psychology, History

• Identifiers
  DOI 10.3233/NRE-2003-18407PMID 14757929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure

  2003cited by this paper
• Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation.

  2003cited by this paper
• Selective denervation: reinnervation for the control of adductor spasmodic dysphonia.

  2003cited by this paper
• Immunologic characterization of spasmodic dysphonia patients who develop resistance to botulinum toxin.

  2003cited by this paper
• Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.

  2002cited by this paper
• The diagnosis and treatment of blepharospasm

  2002cited by this paper
• Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.

  2002cited by this paper
• Botox treatment in adductor spasmodic dysphonia: a meta-analysis.

  2002influential reference
• Thyroplasty for Adductor Spasmodic Dysphonia: Further Experiences

  2001cited by this paper
• Is voice therapy an effective treatment for dysphonia? A randomised controlled trial

  2001cited by this paper
• Cortical dysfunction of the supplementary motor area in a spasmodic dysphonia patient.

  2001cited by this paper
• Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.

  2001cited by this paper
• Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm

  2001cited by this paper
• Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.

  2001cited by this paper
• Adductor Spasmodic Dysphonia and Botulinum Toxin Treatment: The Effect on Well-Being

  2001cited by this paper
• Midline Lateralization Thyroplasty for Adductor Spasmodic Dysphonia

  2000cited by this paper
• Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys.

  2000cited by this paper
• Effects of Botulinum Toxin on Pathophysiology in Spasmodic Dysphonia

  2000cited by this paper
• Progress in Laryngeal Framework Surgery

  2000cited by this paper
• Increased Stability of Airflow Following Botulinum Toxin Injection

  1999cited by this paper
• Selective Laryngeal Adductor Denervationreinnervation: A New Surgical Treatment for Adductor Spasmodic Dysphonia

  1999cited by this paper
• Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys.

  1999cited by this paper
• Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients

  1998cited by this paper
• The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.

  1998cited by this paper
• Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.

  1998cited by this paper
• Bilateral functional MRI activation of the basal ganglia and middle temporal/medial superior temporal motion-sensitive areas: optokinetic stimulation in homonymous hemianopia.

  1998cited by this paper
• Vocal mechanics as the basis for phonosurgery

  1998cited by this paper
• Botulinum Toxin Treatment for Spasmodic Dysphonia: Percutaneous Versus Transoral Approach

  1998cited by this paper
• Emotional symptoms are secondary to the voice disorder in patients with spasmodic dysphonia.

  1998cited by this paper
• Diagnosis and treatment of voice disorders

  1997cited by this paper
• Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.

  1997cited by this paper
• Longitudinal phonatory characteristics after botulinum toxin type A injection.

  1996cited by this paper
• Effects of Botulinum Toxin Type A Injections on Aerodynamic Measures of Spasmodic Dysphonia

  1996cited by this paper
• Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.

  1996cited by this paper
• Alternating Unilateral Botulinum Toxin Type A (BOTOX®) Injections for Spasmodic Dysphonia

  1996cited by this paper
• The basal ganglia: focused selection and inhibition of competing motor programs.

  1996cited by this paper
• Long-Term Effects of Botulinum Toxin Injections in Spasmodic Dysphonia

  1996cited by this paper
• Muscle Tension Dysphonia and Spasmodic Dysphonia: The Role of Manual Laryngeal Tension Reduction in Diagnosis and Management

  1996influential reference
• Laryngeal Muscle Activity During Speech Breaks in Adductor Spasmodic Dysphonia

  1996cited by this paper
• Long-Term Follow-up of Recurrent Laryngeal Nerve Avulsion for the Treatment of Spastic Dysphonia

  1996cited by this paper
• Spasmodic dysphonia associated with a left ventrolateral putaminal lesion

  1996cited by this paper
• Thalamo-olivary degeneration in a patient with laryngopharyngeal dystonia.

  1995cited by this paper
• Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp

  1995cited by this paper
• Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.

  1995cited by this paper
• Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.

  1995cited by this paper
• Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's diseas

  1995cited by this paper
• Technique for Injection of Botulinum Toxin through the Flexible Nasolaryngoscope

  1994cited by this paper
• Comparison of Muscle Activation Patterns in Adductor and Abductor Spasmodic Dysphonia

  1994cited by this paper
• A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.

  1994cited by this paper
• Spasmodic Dysphonia: Emotional Status and Botulinum Toxin Treatment

  1994cited by this paper
• Technique for injection of botulinum toxin through the flexible nasolaryngoscope.

  1994cited by this paper
• Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.

  1993cited by this paper
• Effectiveness of botulinum toxin in the treatment of spasmodic torticollis.

  1993cited by this paper
• Partial Thyroarytenoid Myectomy: An Animal Study Investigating a Proposed New Treatment for Adductor Spasmodic Dysphonia

  1993cited by this paper
• A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias

  1992cited by this paper
• Point-Touch Technique of Botulinum Toxin Injection for the Treatment of Spasmodic Dysphonia

  1992influential reference
• Bilateral Thyroarytenoid Denervation: A New Treatment for Laryngeal Hyperadduction Disorders Studied in the Canine

  1992cited by this paper
• Effects of denervation on laryngeal muscles: A canine model

  1992cited by this paper
• Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: Acoustic, aerodynamic, and videoendoscopic findings

  1992cited by this paper
• Inspiratory Speech as a Management Option for Spastic Dysphonia

  1992cited by this paper
• Recurrent Laryngeal Nerve Avulsion for Treatment of Spastic Dysphonia

  1991influential reference
• Neuroimaging studies do not prove the existence of brain abnormalities in spastic (spasmodic) dysphonia.

  1991cited by this paper
• Resolution of spasmodic dysphonia (focal laryngeal dystonia) via chiropractic manipulative management.

  1991cited by this paper
• Resolution of spasmodic dysphonia (focal laryngeal dystonia) via chiropractic manipulative management.

  1991cited by this paper
• Recurrent Laryngeal Nerve Section for Spastic Dysphonia: 5- to 14-Year Preliminary Results in the First 300 Patients

  1991influential reference
• Treatment options in spasmodic dysphonia.

  1991influential reference
• Autologous fat injection for vocal cord medialization in the canine larynx.

  1991cited by this paper
• Spasmodic Dysphonia: Botulinum Toxin Injection after Recurrent Nerve Surgery

  1990cited by this paper
• Phonosurgery: Theory and Practice

  1990cited by this paper
• Indirect Laryngoscopic Approach for Injection of Botulinum Toxin in Spasmodic Dysphonia

  1990influential reference
• Evidence for cortical dysfunction in spasmodic dysphonia: regional cerebral blood flow and quantitative electrophysiology.

  1990cited by this paper
• Transcutaneous Intrafold Injection for Unilateral Vocal Fold Paralysis: Functional Results

  1990cited by this paper
• Carbon dioxide laser‐assisted thyroarytenoid myomectomy

  1990cited by this paper
• Spasmodic dysphonia, whether and where: results of seven years of research.

  1989cited by this paper
• Laryngeal Framework Surgery in the Management of Spasmodic Dysphonia

  1989cited by this paper
• Clinical and laboratory characteristics of focal laryngeal dystonia: Study of 110 cases

  1988cited by this paper
• Treatment of spasmodic dysphonia by means of resection of the recurrent laryngeal nerve.

  1988cited by this paper
• Blink reflex studies in focal dystonias: Enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis

  1988cited by this paper
• Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia

  1988cited by this paper
• Subglottal air pressure in spastic dysphonia speech.

  1988cited by this paper
• The recurrent laryngeal nerve in spastic dysphonia. A light and electron microscopic study.

  1987cited by this paper
• Dynamic aspects of phonatory control in spasmodic dysphonia.

  1987cited by this paper
• Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

  1987cited by this paper
• Exploration of glottic function before and after injection of collagen for rehabilitation of the vocal cord.

  1986cited by this paper
• Symptom Improvement of Spastic Dysphonia in Response to Phonatory Tasks

  1985cited by this paper
• Intrinsic laryngeal muscle activity in a spastic dysphonia patient.

  1985cited by this paper
• Magnetic Resonance Imaging Findings and Correlations in Spasmodic Dysphonia Patients

  1985cited by this paper
• Spasmodic dysphonia.

  1984cited by this paper
• Laryngeal aerodynamics associated with selected voice disorders.

  1984cited by this paper
• Intermediate results of 306 recurrent laryngeal nerve sections for spastic dysphonia

  1983cited by this paper
• Adductor spastic dysphonia: Three years after recurrent laryngeal nerve resection

  1983cited by this paper
• Problems with surgical (RLN section) treatment of spastic dysphonia

  1983influential reference
• Spastic dysphonia: A surgical and voice therapy treatment program By Herbert H. Dedo and Thomas Shipp, 84 pp, illus, College Hill Press, San Diego, CA, 1980, $13.00

  1982influential reference
• Postoperative and Follow-up Studies of Spastic Dysphonia Patients Treated by Recurrent Laryngeal Nerve Section

  1981cited by this paper
• Adductor Spastic Dysphonia: 1 1/2 Years after Recurrent Laryngeal Nerve Resection

  1981cited by this paper
• Recurrent laryngeal nerve dissection: a case report involving return of spastic dysphonia after initial surgery.

  1980cited by this paper
• Proposed method of intracordal injection and gelation of poly (vinyl alcohol) solution in vocal cords: polymer considerations.

  1980cited by this paper
• Recurrent Laryngeal Nerve Dissection

  1980cited by this paper
• No morphometric abnormality of recurrent laryngeal nerve in spastic dysphonia

  1979cited by this paper
• Spastic dysphonia: treatment by selective section of the recurrent laryngeal nerve.

  1979cited by this paper

• Usefulness of Water-Resistance Straw Phonation in Discrimination of Adductor-Type Spasmodic Dysphonia and Muscle Tension Dysphonia

  2022cites this paper
• Differences in Patient Characteristics between Spasmodic Dysphonia and Vocal Tremor

  2021influential citation
• Proposal for a Core Outcome Set of Measurement Instruments to Assess Quality of Voice in Adductor Spasmodic Dysphonia Based on a Literature Review.

  2020cites this paper
• Adductor Spasmodic Dysphonia Improves with Bilateral Thalamic Deep Brain Stimulation: Report of 3 Cases Done Asleep and Review of Literature

  2020cites this paper
• Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective

  2019cites this paper
• Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Executive Summary

  2018cites this paper
• Spasmodic dysphonia

  2017cites this paper
• The Effect of Information and Severity on Perception of Speakers With Adductor Spasmodic Dysphonia.

  2017cites this paper
• Evaluation of type II thyroplasty on phonatory physiology in an excised canine larynx model

  2017cites this paper
• Speech–Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function

  2017cites this paper
• Employer Reactions to Adductor Spasmodic Dysphonia: Exploring the Influence of Symptom Severity and Disclosure of Diagnosis During a Simulated Telephone Interview.

  2017cites this paper
• Índice de discapacidad vocal pre- y postaplicación de toxina botulínica en pacientes con disfonía espasmódica

  2017cites this paper
• Long-Term Follow-Up of Patients with Spasmodic Dysphonia and Improved Voice despite Discontinuation of Treatment

  2016cites this paper
• Lateral Cricoarytenoid Release

  2016cites this paper
• Botulinum Toxin for Upper Esophageal Sphincter and Larynx

  2015cites this paper
• TITLE : Spasmodic Dysphonia : Evaluation and Management SOURCE : Grand Rounds Presentation , UTMB , Dept . of Otolaryngology DATE : March 10 , 2009 SENIOR MEDICAL STUDENT : Olvia Revelo FACULTY ADVISOR : Michael Underbrink

  2014cites this paper
• Avaliação vocal e da qualidade de vida em pacientes com distonia laríngea em tratamento com toxina botulínica

  2013cites this paper
• The Aspect of Voice Characteristics Change after Botulinum Toxin-A Injection in Patients with Adductor Spasmodic Dysphonia according to Vocal Tremor

  2012cites this paper
• Voice Characteristics of Adductor Spasmodic Dysphonia before and after Botulinum Toxin-A Injection

  2011cites this paper
• Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.

  2010cites this paper
• Psychological aspects of adductor spasmodic dysphonia: a prospective population controlled questionnaire study

  2010cites this paper
• Clinical Practice Guideline: Hoarseness (Dysphonia)

  2009cites this paper
• Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.

  2008cites this paper
• CHAPTER 58 – Medical applications of botulinum neurotoxins

  2006cites this paper
• Contemporary management of spasmodic dysphonia

  2004cites this paper
• Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)

  year unknowncites this paper